MTOR and ganglioneuroma: Treatment of MDA-MB-231 cells with IH, GN, and Aca led to decreases in levels of p-AKT, p-mTOR, p-p70S6K, and p-ULK in a dose-dependent manner (Figs 7A, S8A).